Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (9): 887-890.doi: 10.3736/jcim20080902

• Editorial • Previous Articles     Next Articles

Clinical orientation of post-marketing Chinese patent drugs: an evidence-based practice

Hong-cai Shang1,2,3(), Bo-li Zhang3, You-ping Li1   

  1. 1. Postdoctoral Station of Clinical Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China
    2. Evidence-Based Medicine Centre, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
    3. Academy of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
  • Received:2008-05-08 Online:2008-09-20 Published:2008-09-15

Unclear clinical orientation in practice has become one of the common problems with the effective application of famous and superior Chinese herbal drugs, thus restricting their development. The authors suggest that there are three aspects of this problem. Clinical evaluation and orientation of the famous and superior Chinese herbal drugs is an important task, and it is also a requirement for the internationalization of traditional Chinese medicine. Literature evaluation-pharmacology research-clinical expertise analysis method will establish a theoretical basis and method for post-marketing development of famous and superior Chinese patent drugs.

Key words: Chinese patent drugs, drug evaluation, clinical orientation, evidence-based medicine

CLC Number: 

  • R-31
[1] Zhang BL . Discussion on "say good-bye to traditional Chinese medical science and medicine"(four articles)[J]. Zhong Nan Da Xue Xue Bao She Hui Ke Xue Ban, 2007,13(1):10
张伯礼 . 关于《告别中医中药》的讨论(四篇)——中医学的科学性不容诋毁[J]. 中南大学学报 (社会科学版), 2007,13(1):10
[2] Luo GH . Judgement of traditional Chinese medical science needs science and rationality[J]. Zhong Nan Da Xue Xue Bao She Hui Ke Xue Ban, 2007,9(1):14-15
doi: 10.3969/j.issn.1672-3104.2007.01.004
罗根海 . 评判中医药学需要科学与理性精神[J]. 中南大学学报 (社会科学版), 2007,9(1):14-15
doi: 10.3969/j.issn.1672-3104.2007.01.004
[3] Ernst E . 'First, do no harm' with complementary and alternative medicine[J]. Trends Pharmacol Sci, 2007,28(2):48-50
doi: 10.1016/ pmid: 17222917
[4] Shang HC, Dai GH, Zhang JH , et al. Myocardial infarction secondary prevention study[J]. J Geria Cardiol, 2006,3(2):116-119
[5] Zhao PW, Niu JZ, Wang JF , et al. Phytoestrogenic effects of six active components in Chinese medicine[J]. Zhongguo Yao Xue Za Zhi, 2007,42(24):1852-1855
doi: 10.3321/j.issn:1001-2494.2007.24.004
赵丕文, 牛建昭, 王继峰 , 等. 6种中药活性成分植物雌激素作用的比较研究[J]. 中国药学杂志, 2007,42(24):1852-1855
doi: 10.3321/j.issn:1001-2494.2007.24.004
[6] Verhoog NJ, Joubert E, Louw A . Evaluation of the phytoestrogenic activity of Cyclopia genistoides(honeybush) methanol extracts and relevant polyphenols[J]. J Agric Food Chem, 2007,55(11):4371-4381
doi: 10.1021/jf063588n
[7] Richardson WS, Wilson MC, Nishikawa J , et al.The well-built clinical question: a key to evidence-based decisions[J].ACP J Club, 1995, 123: A12-13
pmid: 7582737
[8] Clarke M . Doing new research? Don't forget the old ― nobody should do a trial without reviewing what is known[J]. PLoS Med, 2004,1(2):e35
doi: 10.1371/journal.pmed.0010035 pmid: 15578106
[9] Ye YA, Li ZH, Tian DL , et al. Some thoughts on evaluation of Chinese medicine clinical curative effect[J]. Liaoning Zhong Yi Za Zhi, 2007,34(2):144-145
doi: 10.3969/j.issn.1000-1719.2007.02.012
叶永安, 李志红, 田德禄 , 等. 关于中医临床疗效评价的一些思考[J]. 辽宁中医杂志, 2007,34(2):144-145
doi: 10.3969/j.issn.1000-1719.2007.02.012
[10] Que HF, Chen HF, Xu JN , et al. Discussion of relationship between quality of life and clinical effect assessment of malignant tumor treated with traditional Chinese medicine[J]. Zhong Xi Yi Jie He Xue Bao, 2005,3(4):253-256
阙华发, 陈红风, 徐杰男 , 等. 生命质量与中医药治疗恶性肿瘤临床疗效评价标准探讨[J]. 中西医结合学报, 2005,3(4):253-256
[1] Arthur de Sá Ferreira, Antonio Guilherme Pacheco. SimTCM: A human patient simulator with application to diagnostic accuracy studies of Chinese medicine. Journal of Integrative Medicine, 2015, 13(1): 9-19.
[2] Li-xin Ma, Yu-yi Wang, Xin-xue Li, Jian-ping Liu . Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(3): 279-292.
[3] Zhu Yan-feng, Luo Hai-ming, Deng Zhong-long, Fu De-yu, Yao Wang, Dai Jian. Effects of the Chinese patent medicine, Honghua Injection, on platelet glycoprotein Ⅱb/Ⅲa receptors in patients with acute coronary syndrome: a randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(3): 318-323.
[4] Jie-ning Wang, Sheng Ye, Dong-hai Yu, Hui Zhao, Le-yi Du. Practice and exploration on clinical evaluations of hospital-made Chinese herbal formulas in the Pudong New Area of Shanghai. Journal of Chinese Integrative Medicine, 2012, 10(10): 1084-1087.
[5] Susuana Kuek, Wen-jun Wang, Sui-qi Gui. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2011, 9(9): 965-972.
[6] Jun-lin Hu, Gui-lin Ouyang, Da-peng Han, Qing Xia, Yong He, Zheng Huang, Fei Zhu, Song-tao Sun. Effects of Tuina and Chinese patent drug Shuxuetong injection on deep venous thrombosis and functional rehabilitation after total knee arthroplasty. Journal of Chinese Integrative Medicine, 2011, 9(10): 1088-1093.
[7] Ming-wei Huang, Huan Wang, Wen-juan Zhong, Xiao-ying Wu, Hui Chen. Chinese herbal medicine Naoxintong capsule combined with dual antiplatelet therapy in a rat model of coronary microembolization induced by homologous microthrombi. Journal of Chinese Integrative Medicine, 2011, 9(1): 38-48.
[8] Si-cheng Wang, Jian-ping Liu, Hui Li, He Yu. Guidelines for evidence-based Chinese medicine clinical pathway report. Journal of Chinese Integrative Medicine, 2010, 8(9): 819-823.
[9] Wan-li Gu , Zai-xiang Shi, Yun-xu Yu, Yu-wei Wu, Bao-wei Lu, Ka-kit Hui . Distribution characteristics of syndrome types in essential hypertension. Journal of Chinese Integrative Medicine, 2010, 8(9): 842-847.
[10] Ling Xu, Li-jing Jiao, Chun-jie Li. Eight-step method in clinical research of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2010, 8(5): 401-405.
[11] Fu-rong Chen , Na Zhang, Ping Liu, Yi-yi Zhang, Xiang-hui Han, Jue-feng Cai. Effects of Guanxinkang on expressions of ATP-sensitive potassium channel subunits Kir6.1, Kir6.2, SUR2A and SUR2B in ischemic myocytes of rats. Journal of Chinese Integrative Medicine, 2010, 8(5): 458-464.
[12] Feng Tian , Yan-ming Xie. Real-world study: A potential new approach to effectiveness evaluation of traditional Chinese medicine interventions. Journal of Chinese Integrative Medicine, 2010, 8(4): 301-306.
[13] Jian-ping Liu. Evidence-based medicine and individualized health care. Journal of Chinese Integrative Medicine, 2009, 7(6): 505-508.
[14] Chung-wah Cheng, Zhao-xiang Bian, You-ping Li, David Moher, Tai-xiang Wu, Simon Dagenais, Jing Li, Ting-qian Li. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials. Journal of Chinese Integrative Medicine, 2008, 6(9): 881-886.
[15] Zhao-xiang Bian, David Moher, You-ping Li, Tai-xiang Wu, Simon Dangenais, Chung-wah Cheng, Jing Li, Ting-qian Li. Appropriately selecting and concisely reporting the outcome measures of randomized controlled trials of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(8): 771-775.
Full text



[1] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[2] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[3] Bing Hu , Hong-mei An , Ke-ping Shen , Qin Du. Senescence-inducing effects of Chinese herbal medicine Tenglong Buzhong Decoction on human colon carcinoma LS-174-T cells and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(11): 1048-1052
[4] Ying Xu , Chang-chun Zeng , Xiu-yu Cai , Rong-ping Guo , Guang Nie , Ying Jin. Chromaticity and optical spectrum colorimetry of the tongue color in different syndromes of primary hepatic carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(11): 1263-1271
[5] Ji Chen, Qin Pan, Li-shuang Ye, Jia-ling Huang. English translation of cultural aspects of the titles of traditional Chinese medicine classics based on the skopos theory. Journal of Chinese Integrative Medicine, 2012, 10(11): 1316-1320
[6] Li-fang Wang, Jin-feng Wang, Wei-fang Jin, Hong-fu Wang, Shao-fen Zhang, Jian-jun Gao. Effects of daidzein on steroid receptor coactivator-1 expression in MC3T3-E1 cells and the mechanism. Journal of Chinese Integrative Medicine, 2011, 9(11): 1248-1253
[7] Liang-ping Hu, Xiao-lei Bao, Xue Guan, Shi-guo Zhou. Estimation of sample size and testing power (Part 3). Journal of Chinese Integrative Medicine, 2011, 9(12): 1307-1311
[8] Jian-sheng Li, Su-yun Li, Xue-qing Yu, Yang Xie. Bufei Yishen Granule combined with acupoint-sticking therapy in patients with stable chronic obstructive pulmonary disease: Study protocol of a multicenter, randomized, double-blind, active-controlled trial. Journal of Chinese Integrative Medicine, 2011, 9(12): 1312-1318
[9] Li Dong-tao, Li Fu-yu, Wang Jian, Liu Ji-hong, Yan Nan, Cheng Yong-mei, Hu Ai-hua, Jiang Hong-yang, Shi Feng-lei, Zhang Mei-zeng, Li Jie, Wei Ling-bo, Jiang Rong-qin. A study of diagnostic criteria for traditional Chinese medicine syndromes in osteoporosis. Journal of Chinese Integrative Medicine, 2011, 9(12): 1326-1332
[10] Oluwole Busayo Akinola, Gabriel Olaiya Omotoso, Oluwafunmike Sharon Akinola, Olufunke Olubusola Dosumu, Esther Tomi Adewoye. Effects of combined leaf extract of Vernonia amygdalina and Azadirachta indica on hepatic morphology and hepatotoxicity markers in streptozotocin-induced diabetic rats. Journal of Chinese Integrative Medicine, 2011, 9(12): 1373-1379